Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 22 (2006), Issue 4, Pages 197-206
http://dx.doi.org/10.1155/2006/586306

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica

Brian G. Weinshenker,1 Dean M. Wingerchuk,4 Sean J. Pittock,1,2 Claudia F. Lucchinetti,1 and Vanda A. Lennon1,2,3

1Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, USA
2Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester MN, USA
3Department of Immunology, Mayo Clinic College of Medicine, Rochester MN, USA
4Department of Neurology, Mayo Clinic Scottsdale, AZ, USA

Received 10 November 2006; Accepted 10 November 2006

Copyright © 2006 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Brian G. Weinshenker, Dean M. Wingerchuk, Sean J. Pittock, Claudia F. Lucchinetti, and Vanda A. Lennon, “NMO-IgG: A Specific Biomarker for Neuromyelitis Optica,” Disease Markers, vol. 22, no. 4, pp. 197-206, 2006. doi:10.1155/2006/586306